🔎 Trials Near Me

Почетна › Гојазност › Тексас › Houston

Kliničke studije za Гојазност u gradu Houston, TX

33 studija za Гојазност traži učesnike na lokacijama u gradu Houston i okolini (u krugu od oko 30 milja). Otvorite studiju da biste videli ko može da učestvuje i kako kontaktirati tim studije.

Zvanični tekst studije (na engleskom)

Tražite učesnike za studiju? Istaknite je na vrhu ove stranice — $99 za 30 dana →

Home Self-administration of Maridebart Cafraglutide With Autoinjector in Adults Living With Obesity or Overweight

Тражи се учесникФаза 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network LLC, Houston
Узраст од 18 до 99 · Оба пола · Ажурирано 9. 11. 2026. · NCT07871409

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes

Тражи се учесникФаза 3
  • Elevate Clinical, Houston
  • Houston Research Institute, Houston
  • Bellaire Clinical Research, LLC, Bellaire · 7 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351045

A Study to Evaluate Effect of AZD6234 as an Adjunct to Incretin-based Therapies in Adult Participants With Obesity or Overweight With Weight-related Comorbidity With or Without Type 2 Diabetes Mellitus

Тражи се учесникФаза 3
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07776509

A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes

Тражи се учесникФаза 3
  • HRI ? Medical Center, LLC, Houston
  • Juno Research, LLC, Houston
Узраст 18 и старији · Оба пола · Ажурирано 9. 11. 2026. · NCT07351058

Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)

Тражи се учесникФаза 3
  • Biopharma Informatic, LLC, Houston
  • Research Physicians Network, LLC, Houston
Узраст од 18 до 99 · Оба пола · Ажурирано 6. 11. 2026. · NCT07575399

A Study to Learn About Study Medicine Called Berobenatide in Adults With Knee Pain and Overweight or Obesity (VESPER-OA 1)

Тражи се учесникФаза 3
  • JCCT-JUNO NW Houston, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07919678

A Study of Orforglipron in Participants With Overweight at Risk of Development of Obesity-Related Complications or Progression to Class 1 Obesity

Тражи се учесникФаза 3
  • Biopharma Informatic, LLC, Houston
  • Care Access - Houston - Clinical Trials Center by Walmart & Care Access, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07794579

A Study to Learn About the Study Medicine Called Berobenatide (PF-08653944) in People With Overweight or Obesity

Тражи се учесникФаза 3
  • PlanIt Research, LLC (Monitoring Room), Houston
  • PlanIt Research, LLC, Houston
Узраст 18 и старији · Оба пола · Ажурирано 5. 11. 2026. · NCT07595549

A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes

Тражи се учесникФаза 3
  • Juno Research, Houston
  • Care Access - Houston - Clinical Trials Center by Walmart & Care Access, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07881458

A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO)

Тражи се учесникФаза 4
  • Center for Clinical Studies, Houston
  • Bellaire Dermatology Associates, Bellaire · 7 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT06857942

A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes

Тражи се учесникФаза 3
  • Juno Research, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07282600

A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin

Тражи се учесникФаза 3
  • Juno Research, Houston
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07392190

Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight

Тражи се учесникФаза 3
  • Care Access - Houston, Houston
  • JCCT - Juno Bellaire Site, Bellaire · 7 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 4. 11. 2026. · NCT07353931

A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)

Тражи се учесникФаза 3
  • McGovern Medical School, Houston
  • Texas Childrens Hospital, Houston
  • Dynamed Clinical Research, LP d/b/a DM Clinical Research, Houston
  • и још 1
Узраст од 6 до 17 · Оба пола · Ажурирано 4. 11. 2026. · NCT06672549

A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide

Тражи се учесникФаза 2
  • Juno Research, Houston
Узраст од 18 до 75 · Оба пола · Ажурирано 4. 11. 2026. · NCT06897475

A Study to Evaluate Effect of AZD6234 in Adult Participants With Obesity or Overweight With Weight-related Comorbidity Without Type 2 Diabetes Mellitus

Тражи се учесникФаза 3
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07784725

A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight

Тражи се учесникФаза 3
  • Research Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 28. 10. 2026. · NCT07784270

Safety and Efficacy of ABBV-295 in Adults With Obesity or Overweight With Weight-Related Comorbidities

Тражи се учесникФаза 2
  • Juno Research /ID# 282413, Houston
  • PlanIt Research /ID# 282204, Houston
  • JCCT - Juno Bellaire /ID# 282263, Bellaire · 7 ми удаљено
Узраст од 18 до 75 · Оба пола · Ажурирано 27. 10. 2026. · NCT07752979

A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)

Тражи се учесникФаза 3Здраве особе су добродошле
  • ACCOMPLISH-2 Research Site, Houston
  • ACCOMPLISH-2 Research Site, Houston
Узраст од 18 до 79 · Оба пола · Ажурирано 20. 10. 2026. · NCT07654374

PROACT AYA: Preventing Overweight/Obesity-Associated Cardiotoxicity With Tirzepatide In Adolescent And Young Adult Cancer Survivors - A Phase 2 Single-Arm, Single-Center Feasibility Study

Тражи се учесникФаза 2
  • UT MD Anderson, Houston
Узраст од 18 до 39 · Оба пола · Ажурирано 20. 10. 2026. · NCT07874828

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

Тражи се учесникФаза 2
  • Baylor College of Medicine, Houston
Узраст 18 и старији · Оба пола · Ажурирано 16. 10. 2026. · NCT06273072

A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight

Тражи се учесникФаза 2
  • PlanIt Research, PLLC, Houston
Узраст од 18 до 75 · Оба пола · Ажурирано 8. 10. 2026. · NCT07589608

A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight

Тражи се учесникФаза 2
  • PlanIt Research, PLLC, Houston
Узраст од 18 до 75 · Оба пола · Ажурирано 7. 10. 2026. · NCT06143956

AMAZE 4: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Тражи се учесникФаза 3
  • Houston Pulm Med Res Network, Houston
Узраст 18 и старији · Оба пола · Ажурирано 7. 10. 2026. · NCT07571109

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-1-EXTENSION)

Тражи се учесникФаза 3
  • Biopharma Informatic, LLC, Houston
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 ми удаљено
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684235

Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)

Тражи се учесникФаза 3
  • Johnson County Clinical Trials Juno Bellaire, Bellaire · 7 ми удаљено
Узраст од 18 до 99 · Оба пола · Ажурирано 5. 10. 2026. · NCT07684144

A Research Study on How Well Cagrilintide and CagriSema Work in Children and Adolescents With Excess Body Weight

Тражи се учесникФаза 3
  • DM Clinical, Houston
Узраст од 8 до 18 · Оба пола · Ажурирано 30. 9. 2026. · NCT07253285

A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide

Тражи се учесникФаза 3
  • Houston Research Institute, Houston
  • The Endocrine Center, Houston
Узраст 18 и старији · Оба пола · Ажурирано 28. 9. 2026. · NCT07668414

A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes

Тражи се учесникФаза 3
  • The University of Texas Health Science Center at Houston, Bellaire · 7 ми удаљено
Узраст 18 и старији · Оба пола · Ажурирано 22. 9. 2026. · NCT07321886

Semaglutide for Post-Smoking Cessation Weight Management

Тражи се учесникФаза 2Здраве особе су добродошле
  • The University of Texas Health Science Center at Houston, Houston
Узраст од 18 до 75 · Оба пола · Ажурирано 21. 9. 2026. · NCT06173778

A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes

Тражи се учесникФаза 3
  • AURORA-2 Clinical Site, Houston
Узраст 18 и старији · Оба пола · Ажурирано 16. 9. 2026. · NCT07743450

AMAZE 3: A Research Study Investigating How Well the Medicine NNC0487-0111 Helps People With Excess Body Weight and Obstructive Sleep Apnoea Not Treated With Positive Airway Pressure Lose Weight and Improve Sleep Apnoea

Тражи се учесникФаза 3
  • Houston Pulm Med Res Network, Houston
Узраст 18 и старији · Оба пола · Ажурирано 11. 9. 2026. · NCT07571005

Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)

Тражи се учесникФаза 3
  • ACCOMPLISH-1 Research Site, Houston
  • ACCOMPLISH-1 Research Site, Houston
Узраст од 18 до 79 · Оба пола · Ажурирано 10. 8. 2026. · NCT07654361

Studije za Гојазност u drugim gradovima

Ostale studije u gradu Houston

Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.